Snowball logo
logo
Оценка
EPS
-0,01
Бета
35,346
Другое
Размер лота
1 шт.
О компании
Тикер
SCIE
ISIN
US84760E3018
Страна
США
Сектор (GICS)
Здравоохранение
SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.

Часто задаваемые вопросы

В каком секторе работает Spectrascience New (SCIE)?

Spectrascience New относится к сектору Здравоохранение.

Какова текущая цена акций Spectrascience New (SCIE)?

По последним данным, цена акций Spectrascience New составляет 1,42 $, предыдущее закрытие — 1,42 $.

Выплачивает ли Spectrascience New (SCIE) дивиденды?

Нет, Spectrascience New не выплачивает дивиденды.

Какой бета-коэффициент (волатильность) у Spectrascience New (SCIE)?

У компании Spectrascience New бета 35.346, что свидетельствует о крайне высокой волатильности по сравнению с рынком